Benitec Biopharma (BNTC) Receivables - Other (2019 - 2020)

Benitec Biopharma (BNTC) posted Receivables - Other of $21000.0 for Q4 2020, down 64.41% sequentially from $59000.0 in Q2 2020.

Benitec Biopharma (BNTC) Receivables - Other (2019 - 2020) Analysis & Trends

Benitec Biopharma has reported Receivables - Other for 2 years, with the latest figure at $21000.0 in Q4 2020.

Quarterly Receivables - Other changed N/A year-over-year to $21000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $21000.0 (changed N/A YoY) and the FY2020 annual result came in at $59000.0, down 96.89% from the prior year.
Receivables - Other fell to $21000.0 in Q4 2020 per BNTC's latest filing, from $59000.0 in the prior quarter.
Over five years, Receivables - Other peaked at $1.9 million in Q2 2019 and troughed at $21000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Benitec Biopharma	577.39 Mn	388.49 Mn	-

Download Data